240 related articles for article (PubMed ID: 10732744)
1. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
van Herpen CM; Jansen RL; Kruit WH; Hoekman K; Groenewegen G; Osanto S; De Mulder PH
Br J Cancer; 2000 Feb; 82(4):772-6. PubMed ID: 10732744
[TBL] [Abstract][Full Text] [Related]
2. Combination of interleukin-2 and interferon-alpha in renal cell carcinoma and malignant melanoma: a phase II clinical trial.
Veelken H; Rosenthal FM; Schneller F; von Schilling C; Guettler IC; Herrmann F; Mertelsmann R; Lindemann A
Biotechnol Ther; 1992; 3(1-2):1-14. PubMed ID: 1305889
[TBL] [Abstract][Full Text] [Related]
3. Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.
Figlin RA; Belldegrun A; Moldawer N; Zeffren J; deKernion J
J Clin Oncol; 1992 Mar; 10(3):414-21. PubMed ID: 1482425
[TBL] [Abstract][Full Text] [Related]
4. A phase 2 trial of recombinant interleukin-2 and 5-fluorouracil in patients with metastatic colorectal carcinoma.
Reid I; Sharpe I; Maxwell W; McDevitt J; Franks CR; Tanner WA; Monson JR
Eur J Surg Oncol; 1992 Dec; 18(6):591-8. PubMed ID: 1478292
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment natural killer antigen density correlates to clinical response in tumor patients receiving long-term subcutaneous recombinant interleukin-2 and recombinant interferon-alpha.
Duensing S; Hadam M; Körfer A; Schomburg A; Menzel T; Grosse J; Kirchner H; Poliwoda H; Atzpodien J
Mol Biother; 1992 Dec; 4(4):170-3. PubMed ID: 1282326
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors].
Niijima T; Akaza H; Koyanagi T; Togashi M; Kumamoto Y; Funyu T; Suzuki T; Orikasa S; Yoshikawa K; Koiso K
Hinyokika Kiyo; 1992 Oct; 38(10):1201-7. PubMed ID: 1481783
[TBL] [Abstract][Full Text] [Related]
7. Our experience with interferon alpha: renal cell carcinoma.
Merimsky O; Chaitchik S
Mol Biother; 1992 Sep; 4(3):130-4. PubMed ID: 1445666
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of advanced renal cell carcinoma with interferon alpha and OK-432 (streptococcal preparation)].
Shinoda M; Naide Y
Hinyokika Kiyo; 1992 Nov; 38(11):1299-304. PubMed ID: 1485585
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma.
Ilson DH; Motzer RJ; Kradin RL; Vogelzang NJ; Bajorin DF; Scher HI; Nanus D; O'Moore P; Marathias K; Bosl GJ
J Clin Oncol; 1992 Jul; 10(7):1124-30. PubMed ID: 1607918
[TBL] [Abstract][Full Text] [Related]
11. Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study.
Stahl M; Schmoll E; Becker H; Schlichter A; Hoffmann L; Wagner H; Possinger K; Müller W; Köllermann M; Weidenhammer W
Semin Oncol; 1991 Apr; 18(2 Suppl 4):33-7. PubMed ID: 2031196
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine.
Kotake T; Kinouchi T; Saiki S; Kuroda M; Miki T; Kiyohara H; Usami M
Jpn J Clin Oncol; 1991 Feb; 21(1):46-51. PubMed ID: 2067120
[TBL] [Abstract][Full Text] [Related]
13. A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.
Pazdur R; Ajani JA; Winn R; Bearden J; Belt RJ; Pilat S; Hallinan R; Levin B
Cancer; 1992 Feb; 69(4):878-82. PubMed ID: 1735078
[TBL] [Abstract][Full Text] [Related]
14. [Interferon therapy for advanced renal cell carcinoma].
Fujita T; Fukushima M
Hinyokika Kiyo; 1992 Nov; 38(11):1293-8. PubMed ID: 1485584
[TBL] [Abstract][Full Text] [Related]
15. Combination fluorouracil, folinic acid, and interferon alfa-2a: an active regimen in advanced pancreatic carcinoma.
Knuth A; Bernhard H; Klein O; Meyer zum Büschenfelde KH
Semin Oncol; 1992 Apr; 19(2 Suppl 3):211-4. PubMed ID: 1557650
[TBL] [Abstract][Full Text] [Related]
16. Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection.
Abi-Aad AS; Figlin RA; Belldegrun A; deKernion JB
J Immunother (1991); 1991 Aug; 10(4):292-5. PubMed ID: 1931865
[TBL] [Abstract][Full Text] [Related]
17. Combination biotherapy utilizing interleukin-2 and alpha interferon in patients with advanced cancer: a National Biotherapy Study Group Trial.
Oldham RK; Blumenschein G; Schwartzberg L; Birch R; Arnold J
Mol Biother; 1992 Mar; 4(1):4-9. PubMed ID: 1627272
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of recombinant human interferon-gamma in metastatic renal cell carcinoma.
Bruntsch U; de Mulder PH; ten Bokkel Huinink WW; Clavel M; Drozd A; Kaye SB; Renard J; van Glabbeke M
J Biol Response Mod; 1990 Jun; 9(3):335-8. PubMed ID: 2116500
[TBL] [Abstract][Full Text] [Related]
19. [Role of interferon in the treatment of renal cancer in adults].
Bergerat JP; Dufour P
Rev Prat; 1992 May; 42(10):1246-52. PubMed ID: 1376937
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: a pilot study.
Westermann J; Reich G; Kopp J; Haus U; Dörken B; Pezzutto A
Cancer Immunol Immunother; 2001 Jan; 49(11):613-20. PubMed ID: 11225992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
